StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.87−0.03 (-3.33%)

Close on Nov 13, 2026Market cap $14.51MP/E –Yield –

Marker Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2012 it was $67.94K, down 32.1% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2012Dec 31, 2012$67.94K-32.1%
FY2011Dec 31, 2011$100.00K–

More Marker Therapeutics figures

See a number that looks wrong?